Liver Enzyme Elevations - Infectious Diseases

Relevant Publications

Effects of the Interaction between Rumen Microbiota Density-VFAs-Hepatic Gluconeogenesis on the Adaptability of Tibetan Sheep to Plateau.

Issue Release: 2024

AIDS-Associated Cryptosporidial and Cytomegalovirus Cholangiopathy.

Issue Release: 2024

Elevated serum hepatic transaminases in apical periodontitis individuals.

Issue Release: 2024

Safety profile of proprotein convertase subtilisin/kexin type 9 inhibitors alirocumab and evolocumab: an updated meta-analysis and meta-regression.

Issue Release: 2024

Hepatic micro-abscesses as an unusual initial presentation of systemic lupus erythematosus: A case report.

Issue Release: 2024

Alterations in Alanine Transaminase, Aspartate Transaminase, Gamma-Glutamyl Transpeptidase, and Creatine Kinase in Acne Patients Undergoing Isotretinoin Treatment: A Retrospective Evaluation of Laboratory Tests.

Issue Release: 2024

Metabolic Activation and Cytotoxicity of Gramine Mediated by CYP3A in Rats.

Issue Release: 2024

Safety and Dose-Response of Vidofludimus Calcium in Relapsing Multiple Sclerosis: Extended Results of a Placebo-Controlled Phase 2 Trial.

Issue Release: 2024

JuA alleviates liver ischemia-reperfusion injury by activating AKT/NRF2/HO-1 pathways.

Issue Release: 2024

BILIARY DUCTAL PLATE MALFORMATION WITH SECONDARY PORTAL HYPERTENSION AND MULTIPLE ACQUIRED SHUNTS IN A LITTER OF AMUR TIGERS ().

Issue Release: 2024

Clinical guidance for cannabidiol-associated hepatotoxicity: A narrative review.

Issue Release: 2024

Randomized, placebo-controlled, double-blind phase I trial of co-administered pyronaridine and piperaquine in healthy adults of sub-Saharan origin.

Issue Release: 2024

Safety of naltrexone in patients with cirrhosis.

Issue Release: 2024

Complement System Response to Adeno-Associated Virus Vector Gene Therapy.

Issue Release: 2024

Leflunomide with prednisone or nonsteroidal anti-inflammatory drug therapy is safe and tolerated for long-term treatment of immune-mediated polyarthritis in 27 dogs.

Issue Release: 2024

Prediction of the Liver Safety Profile of a First-in-Class Myeloperoxidase Inhibitor Using Quantitative Systems Toxicology Modeling.

Issue Release: 2024

Medication use evaluation of tocilizumab implementation in COVID-19 treatment guidelines: A causal inference approach.

Issue Release: 2024

PARP inhibition with rucaparib alone followed by combination with atezolizumab: Phase Ib COUPLET clinical study in advanced gynaecological and triple-negative breast cancers.

Issue Release: 2024

Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials.

Issue Release: 2024

Serial evaluation of liver enzyme activities in dogs with pulmonary coccidioidomycosis administered fluconazole.

Issue Release: 2024

How Can Food and Water Contamination be Prevented?

What Are the Global Efforts?

What is Ventilation?

How Can HPV Infection be Prevented?

What Are Vector-Borne Diseases and How Are They Affected?

What About Monogamy and Antibiotic Resistance?

How Does WHO Ensure Compliance with Health Regulations?

How is Hepatitis B Diagnosed?

How are Structural Proteins Targeted in Vaccine Development?

What Illnesses Do Adenoviruses Cause?

Partnered Content Networks

Relevant Topics